Login
Username
Password
Forgot Password?
New User
 
Most Discussed Stocks
ALNYLAM PHARMACEUTICALS, ALNY
AMGEN, AMGN
BIOGEN IDEC, BIIB
CYTOKINETICS, CYTK
DENDREON,DNDN
DYAX, DYAX
ELAN, ELN
GENENTECH,DNA
GILEAD SCIENCES,GILD
ONYX PHARMACEUTICALS,ONXX
OSIRIS THERAPEUTICS, OSIR
REGENERON,RGEN
SAVIENT PHARMACEUTICALS, SAVIENT (SVNT)
SEQUENOM,SQNM
SANGAMO BIOSCIENCES, SGMO
EXELIXIS, EXEL
   more

Biotech News and Comments

EURAND (EURX) EXPECTS APPROVAL FOR ZENPEP, ITS PANCREATIC ENZYME
Why do we need the pancreatic enzyme developed by EURAND (EURX)?

 

more

News and Comments

more
MEDAREX (MEDX): IPILIMUMAB, A PMISING THERAPE.... 06/22/2009
  The time has come for Medarex' recognition. The firm's Ipilimumab turned inoperable prostate cancer into operable tumor. The patients were able to resume their lives.

SAVIENT IS WORTH MUCH MORE THAN WHAT IS GOING.... 06/18/2009
  Do you know that SVNT was brought down by perpetrated fear from near $20 in September 2008 to around $3 in October of the same year. The stock is worth much more.

SAVIENT: WHY KRYSTEXXA’S REWARD OUTWEIGHS THE.... 06/16/2009
  The FDA Committee will meet to discuss Savient's drug Krystexxa. What do we think?

SEQUENOM: WHY HAVE SHORT SELLERS PANICKED? 06/10/2009
 

HEMISPHERX (HEB) AND ANTIGENICS (AGEN): INDIS.... 06/05/2009
  This is about adjuvants that are empowering preventive and therapeutic vaccines. Both Hemispherx and Antigenics have them and other firms too.

ASCO: THE TIME HAS COME FOR THERAPEUTIC VACCI.... 06/03/2009
  Old drugs, new drugs, breakthrough drugs, combinations of drugs and radiation, in addition to useless drugs - all are presented to oncologists from allover the world at ASCO. Unli....

EYE ON ONXX AND OSIP 05/29/2009
  For subscribers only.

 

Latest News Posted to subscribers

more
PROHOST LETTER #287
PROHOST LETTER #286
PROHOST LETTER #285
PROHOST LETTER #284
PROHOST LETTER #283
PROHOST LETTER #282
 

Topics

 

Prohost Letters

PROHOST LETTER #287
PROHOST LETTER #286
PROHOST LETTER #285
PROHOST LETTER #284
PROHOST LETTER #283
PROHOST E-LETTER #277
PROHOST E-LETTER #276 PART 2
PROHOST E-LETTER #276
PROHOST E-LETTER #275
PROHOST E-LETTER #274